• 🌍 Redefining the Future of Digital Therapeutics & Healthcare Innovation

    CIO Times is proud to feature Ismael Maceira Lecanda, CEO & Co-founder of SAMIRA DTx, in the latest edition of HealthTech Innovator of the Year 2026.

    Driven by personal experience and an unwavering commitment to improving the lives of patients with chronic diseases, Ismael is pioneering the future of digital therapeutics through AI-powered, patient-centric healthcare solutions. His visionary leadership and passion for innovation are transforming the way healthcare is delivered—making it more personalized, accessible, and impactful.

    Discover his inspiring journey and learn how SAMIRA DTx is shaping the next generation of HealthTech innovation.

    πŸ”— Feature Story: https://theciotimes.com/ismael-maceira-samira-dtx/
    πŸ”— Latest Edition: https://theciotimes.com/magazine/HealthTech-Innovator-of-the-Year-2026/

    #CIOTimes #HealthTechInnovator #IsmaelMaceiraLecanda #SAMIRADTx #HealthTech #DigitalTherapeutics #HealthcareInnovation #ArtificialIntelligence #PatientCentricCare #DigitalHealth #HealthcareLeadership #Innovation #FutureOfHealthcare #HealthTech2026
    🌍 Redefining the Future of Digital Therapeutics & Healthcare Innovation CIO Times is proud to feature Ismael Maceira Lecanda, CEO & Co-founder of SAMIRA DTx, in the latest edition of HealthTech Innovator of the Year 2026. Driven by personal experience and an unwavering commitment to improving the lives of patients with chronic diseases, Ismael is pioneering the future of digital therapeutics through AI-powered, patient-centric healthcare solutions. His visionary leadership and passion for innovation are transforming the way healthcare is delivered—making it more personalized, accessible, and impactful. Discover his inspiring journey and learn how SAMIRA DTx is shaping the next generation of HealthTech innovation. πŸ”— Feature Story: https://theciotimes.com/ismael-maceira-samira-dtx/ πŸ”— Latest Edition: https://theciotimes.com/magazine/HealthTech-Innovator-of-the-Year-2026/ #CIOTimes #HealthTechInnovator #IsmaelMaceiraLecanda #SAMIRADTx #HealthTech #DigitalTherapeutics #HealthcareInnovation #ArtificialIntelligence #PatientCentricCare #DigitalHealth #HealthcareLeadership #Innovation #FutureOfHealthcare #HealthTech2026
    THECIOTIMES.COM
    SAMIRA DTx | Ismael Maceira | Future of Healthcare Through Patient-Centered Innovation| CIO Times Magazine
    Among them is Ismael Maceira, CEO and Co-founder of SAMIRA DTx, who is redefining patient care through innovativePrescription Digital Therapeutics (DTx). Read for more information
    0 Comments 0 Shares
  • Anti Snoring Devices Market to Reach US$ 2.06 Billion by 2033 Growth, Trends & Forecast
    Anti-snoring devices are medical and wellness products developed to reduce snoring by improving airflow and preventing airway blockage during sleep. They help enhance sleep quality, promote better breathing, and lower the risk of health issues associated with persistent snoring and mild to moderate obstructive sleep apnea. Common anti-snoring solutions include mandibular advancement devices,...
    0 Comments 0 Shares
  • Anti Snoring Devices Market to Reach US$ 2.06 Billion by 2033 Growth, Trends & Forecast
    Anti-snoring devices are advanced sleep therapy solutions designed to reduce snoring by maintaining an open airway throughout the night. By improving airflow and minimizing airway collapse, these devices support better sleep quality, enhance breathing comfort, and help lower the risk of complications associated with persistent snoring and mild to moderate obstructive sleep apnea. Available in...
    0 Comments 0 Shares
  • ASEAN Vagus Nerve Stimulation Devices Market Expected to Grow at a 9.9% CAGR Through 2033
    Vagus nerve stimulation (VNS) devices are specialized neuromodulation systems that deliver gentle electrical impulses to the vagus nerve to regulate abnormal nerve activity and enhance communication between the brain and the body's organs. This therapy is designed to improve neurological function and provide long-term symptom relief for patients with chronic neurological and psychiatric...
    0 Comments 0 Shares
  • ASEAN Vagus Nerve Stimulation Devices Market Expected to Grow at a 9.9% CAGR Through 2033
    Vagus nerve stimulation (VNS) devices are innovative medical devices that use controlled electrical stimulation of the vagus nerve to help regulate brain function and support communication between the brain and the body's organs. They are primarily used to treat neurological conditions such as drug-resistant epilepsy and treatment-resistant depression, while emerging research is expanding their...
    0 Comments 0 Shares
  • ASEAN Vagus Nerve Stimulation Devices Market Expected to Grow at a 9.9% CAGR Through 2033
    Vagus nerve stimulation (VNS) devices are specialized neuromodulation systems that deliver gentle electrical impulses to the vagus nerve to regulate abnormal nerve activity and enhance communication between the brain and the body's organs. This therapy is designed to improve neurological function and provide long-term symptom relief for patients with chronic neurological and psychiatric...
    0 Comments 0 Shares
  • BRICS Spinal Cord Stimulation Devices Market Set for 9.4% CAGR Through 2033
    Spinal cord stimulation (SCS) devices are innovative implantable medical technologies that use mild electrical impulses to block or modify pain signals traveling through the spinal cord before they reach the brain. They are widely used to treat chronic pain conditions, including persistent back pain, neuropathic pain, failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS),...
    0 Comments 0 Shares
  • BRICS Spinal Cord Stimulation Devices Market Set for 9.4% CAGR Through 2033
    Spinal cord stimulation (SCS) devices are advanced implantable neuromodulation systems that help relieve chronic pain by delivering controlled electrical pulses to the spinal cord. These pulses modify pain signal transmission before it reaches the brain, offering sustained pain relief for patients with conditions such as chronic back pain, neuropathic pain, failed back surgery syndrome (FBSS),...
    0 Comments 0 Shares
  • BRICS Spinal Cord Stimulation Devices Market Set for 9.4% CAGR Through 2033
    Spinal cord stimulation (SCS) devices are advanced implantable neuromodulation systems that help relieve chronic pain by delivering controlled electrical pulses to the spinal cord. These pulses modify pain signal transmission before it reaches the brain, offering sustained pain relief for patients with conditions such as chronic back pain, neuropathic pain, failed back surgery syndrome (FBSS),...
    0 Comments 0 Shares
  • Cardiovascular Ultrasound Market Size to Reach US$ 4.38 Billion by 2033, Expanding at a CAGR of 5.85% from 2026 to 2033
    Cardiovascular ultrasound is a non-invasive imaging technology that uses high-frequency sound waves to generate detailed, real-time images of the heart and cardiovascular system. It allows physicians to evaluate heart anatomy, assess blood flow, monitor valve function, and detect abnormalities such as congenital defects, heart failure, and other cardiovascular disorders. Widely used in...
    0 Comments 0 Shares
  • Cardiovascular Ultrasound Market Size to Reach US$ 4.38 Billion by 2033, Expanding at a CAGR of 5.85% from 2026 to 2033
    Cardiovascular ultrasound is a non-invasive imaging technology that uses high-frequency sound waves to generate detailed, real-time images of the heart and cardiovascular system. It allows physicians to evaluate heart anatomy, assess blood flow, monitor valve function, and detect abnormalities such as congenital defects, heart failure, and other cardiovascular disorders. Widely used in...
    0 Comments 0 Shares
No data to show
No data to show
No data to show
No data to show